Literature DB >> 8222568

Community-acquired pneumonia in the elderly patient. Clinical features, epidemiology, and treatment.

J T Granton1, R F Grossman.   

Abstract

The relationship between age and the incidence of and mortality associated with pneumonia is complex. Age itself may not be an independent risk factor, because elderly patients also have a concomitant increase in the number of underlying risk factors for disease. The authors review the clinical features, epidemiology, and treatment of community-acquired pneumonia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222568

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  7 in total

1.  Measuring the impact of influenza on the hospital admission rates of the elderly in Ontario: a five-year admission rate analysis, 1988-1993.

Authors:  R E Upshur; V Goel
Journal:  Can J Public Health       Date:  2000 Mar-Apr

2.  Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.

Authors:  A C Soares; V S Pinho; D G Souza; T Shimizu; S Ishii; J R Nicoli; M M Teixeira
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 3.  Community-acquired pneumonia in the elderly: a practical guide to treatment.

Authors:  D Lieberman; D Lieberman
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

4.  Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia.

Authors:  L L Laichalk; S L Kunkel; R M Strieter; J M Danforth; M B Bailie; T J Standiford
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Community-acquired pneumonia and its predictors of mortality in rural southwestern Nigeria: A-five year retrospective observational study.

Authors:  Azeez Oyemomi Ibrahim; Olabode Muftau Shabi; Shuaib Kayode Aremu; Emmanuel Olusegun Omosanya; Fasanmi Tolulope Kolawole; Adewumi Oluwaserimi Ajetunmobi
Journal:  Afr J Emerg Med       Date:  2022-06-24

6.  Impaired host defense to Klebsiella pneumoniae infection in mice treated with the PDE4 inhibitor rolipram.

Authors:  A C Soares; D G Souza; V Pinho; A T Vieira; M M Barsante; J R Nicoli; M Teixeira
Journal:  Br J Pharmacol       Date:  2003-11       Impact factor: 8.739

Review 7.  Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention.

Authors:  Lavida R K Brooks; George I Mias
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.